Samsrita Labs Completes Q3 FY26 Financial Results Publication Under Regulation 47

2 min read     Updated on 06 Feb 2026, 04:35 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Samsrita Labs Limited completed mandatory newspaper publication of Q3 FY26 financial results under Regulation 47, reporting significant loss widening to ₹335.56 lakhs from ₹4.05 lakhs in previous year, primarily driven by major intangible asset write-off worth ₹3.26 crore due to technological obsolescence.

31921514

*this image is generated using AI for illustrative purposes only.

Samsrita Labs Limited has completed the mandatory newspaper publication of its unaudited financial results for the third quarter of FY26, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported a substantial widening of losses for the quarter, with net loss reaching ₹335.56 lakhs compared to ₹4.05 lakhs in the corresponding quarter of the previous year.

Regulatory Compliance and Publication

The company published its financial results in Financial Express (English newspaper) and Nava Telangana (Telugu newspaper) on February 7, 2026. The publication included QR codes and webpage details where complete unaudited standalone and consolidated financial results are accessible to investors.

Compliance Parameter: Details
Publication Date: February 7, 2026
English Newspaper: Financial Express
Regional Newspaper: Nava Telangana (Telugu)
Board Approval Date: February 6, 2026
Regulation: SEBI Regulation 47

Financial Performance Overview

The healthcare sector company's financial performance was significantly impacted by a major asset write-off during the quarter ended December 31, 2025. The primary driver of the increased losses was a significant write-off of intangible assets under development worth ₹3,25,95,369.

Metric: Q3 FY26 Q3 FY25 Change
Net Loss: ₹335.56 lakhs ₹4.05 lakhs Increased significantly
Total Expenses: ₹335.56 lakhs ₹4.05 lakhs Increased substantially
Employee Benefits: ₹5.32 lakhs ₹2.76 lakhs +92.75%
Other Expenses: ₹330.21 lakhs ₹1.26 lakhs Increased substantially
Basic EPS: ₹(1.48) ₹(0.03) Declined

Nine-Month Performance

The nine-month period ended December 31, 2025, showed similarly concerning trends with net loss reaching ₹856.72 lakhs compared to ₹17.25 lakhs in the previous year. The company's paid-up equity share capital stood at ₹2,274.97 lakhs as of December 31, 2025, compared to ₹1,480.87 lakhs in the previous year.

Asset Write-off Impact

The company stated that the intangible asset write-off was necessitated by technological obsolescence, as the underlying patents are no longer expected to provide future economic benefits. This write-off was recognized in the Statement of Profit and Loss for the quarter and represents a substantial one-time charge affecting the company's financial performance.

Board Approval and Accessibility

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 6, 2026. The complete results are available on stock exchange websites ( www.bseindia.com and www.msei.in ) and the company's webpage, accessible through QR codes published in the newspapers. The results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by statutory auditors.

Historical Stock Returns for Samsrita Labs

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.47%-2.82%-6.59%-4.45%-48.64%

Samsrita Labs Promoters Reduce Stake: Krishnam Raju Kalidindi and Dr. Mohammed Aejaz Habeeb Sell Shares

1 min read     Updated on 17 Nov 2025, 01:14 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Two promoters of Samsrita Labs Limited have reduced their stakes through off-market transfers. Krishnam Raju Kalidindi sold 2,00,000 shares (0.88%) on 21-11-2025, while Dr. Mohammed Aejaz Habeeb transferred 7,38,000 shares (3.24%) on 12-11-2025. These transactions have decreased the promoter group's total shareholding from 26.32% to 22.20%.

24911071

*this image is generated using AI for illustrative purposes only.

Samsrita Labs Limited , a company listed on the BSE and Metropolitan Stock Exchange of India, has reported significant changes in its promoter shareholding. Two promoters of the company have reduced their stakes through off-market transfers.

Key Details of the Transactions

Aspect Transaction 1 Transaction 2
Promoter Name Krishnam Raju Kalidindi Dr. Mohammed Aejaz Habeeb
Number of Shares Sold 2,00,000 7,38,000
Percentage of Total Shareholding 0.88% 3.24%
Mode of Transfer Off-market Off-market
Date of Transaction 21-11-2025 12-11-2025

Impact on Promoter Group Holding

The off-market transfers have led to a reduction in the promoter group's collective shareholding in Samsrita Labs Limited.

Shareholding Before Kalidindi's Transaction After Kalidindi's Transaction After Habeeb's Transaction
Promoter Group Holding 26.32% 25.44% 22.20%
Change in Holding - -0.88% -3.24%

These transactions mark shifts in the ownership structure of Samsrita Labs Limited. The reduction in promoter holding could potentially impact the company's governance and decision-making processes.

Investors and market watchers may want to monitor any further disclosures or announcements from the company regarding these changes in shareholding pattern. It's important to note that off-market transfers can occur for various reasons, including restructuring within the promoter group, strategic realignments, or personal financial decisions of the promoters.

Shareholders and potential investors should consider this information in the context of the company's overall performance and market conditions before making any investment decisions.

Historical Stock Returns for Samsrita Labs

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.47%-2.82%-6.59%-4.45%-48.64%

More News on Samsrita Labs

1 Year Returns:-4.45%